Mail-Order Pharmacy Cannot Replace Local Access for Millions of Patients

The standard industry response to pharmacy closures is that mail-order pharmacy can fill the gap. In reality, mail-order is unsuitable or inaccessible for large segments of the population most affected by pharmacy deserts. Controlled substances like opioid pain medications cannot be mailed in most cases. Temperature-sensitive medications including insulin and biologics face cold-chain integrity risks -- a study found that none of five common packaging technologies maintained the required 36-46 degrees Fahrenheit range during the first 24 hours of shipping, and the critical last-mile delivery window exposes medications to extreme temperatures when left on doorsteps. Delivery times of 3-14 business days are unacceptable for acute prescriptions like antibiotics or rescue inhalers. Beyond logistics, mail-order pharmacy eliminates the clinical interaction that makes community pharmacies a healthcare access point. Pharmacists catch an estimated 2 billion potential medication errors per year through face-to-face counseling, drug utilization reviews, and real-time consultations with prescribers. A mail-order pharmacist reviewing a prescription on screen does not see the patient's physical condition, does not notice the signs of a drug interaction manifesting, and does not have the relationship context to ask probing questions. For elderly patients managing five or more medications -- a group that includes 40% of Americans over 65 -- this personal clinical relationship is a safety net, not a convenience. Mail-order also assumes stable housing with a secure delivery location, reliable internet or phone access to place orders, and the cognitive and organizational capacity to plan refills two weeks in advance. Homeless individuals, people in domestic violence shelters, patients with cognitive decline, and those in unstable housing situations cannot reliably receive mail-order medications. These are precisely the populations with the highest healthcare needs and the least ability to travel to distant pharmacies. This problem persists because mail-order pharmacy is enormously profitable for PBMs -- it eliminates the independent pharmacy middleman entirely and captures the full dispensing margin. PBMs have a direct financial incentive to promote mail-order as a substitute for local pharmacy access, regardless of whether it actually serves the patient population's needs. The narrative that mail-order solves the pharmacy desert problem provides political cover for allowing brick-and-mortar closures to continue unchecked.